Nalaganje...
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
BACKGROUND: An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the first country to implement a national prevention campaign, vaccinating 11.4 million people ag...
Shranjeno v:
| izdano v: | Lancet Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831863/ https://ncbi.nlm.nih.gov/pubmed/22818241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(12)70168-8 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|